Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT05473338Unknown

Complex Regional Pain Syndrome (CRPS) and the Gut-bacteria

Role: collaborator

NCT05329571Not ApplicableUnknown

The Effects of Dietary Changes on Gut-bacteria and Fibromyalgia Symptoms

Role: collaborator

NCT05213065Not ApplicableUnknown

Assessment of the Efficacy of the Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Daily Headache in Children and Adolescents.

Role: collaborator

All 3 trials loaded